Blood-Derived injection shows promise for dry AMD
NCT ID NCT07428798
First seen Mar 14, 2026 · Last updated May 22, 2026 · Updated 10 times
Summary
This study tested whether injecting a concentrated form of the patient's own blood, called platelet-rich plasma (PRP), into the eye could slow the progression of advanced dry age-related macular degeneration (AMD). Fourteen people with dry AMD in both eyes received three PRP injections in one eye, while the other eye was left untreated as a comparison. The goal was to see if the treated eye had less damage to the retina and better vision over 10 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Marmara University School of Medicine, Department of Ophthalmology
Istanbul, Istanbul, 34899, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.